GO-203-2C + Bortezomib For Relapsed Or Refractory MM

Clinical trial NCT02658396 · WITHDRAWN

Trial details

NCT number: NCT02658396
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma in Relapse Refractory Multiple Myeloma

Primary completion: 2019-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.